Aikvira Pharmaceuticals Private Limited
About Aikvira Pharmaceuticals Private Limited
Data last updated:
Aikvira Pharmaceuticals Private Limited is a private limited company based in Thane, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 12 May 2023.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U21009MH2023PTC402838.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sidharth Sitaram Lad and Richa Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thane, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹1 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹36,425 (net margin 36.4%) and EBITDA of ₹49,222 (EBITDA margin 49.1%).
Company details
Contact details
Aikvira Pharmaceuticals Private Limited's registered office is in Thane, Maharashtra.
- Registered AddressOffice No 16 1st Flr Gb, Road Tropical Lagoon Tl5, Thane, Maharashtra, India – 400615
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Aikvira Pharmaceuticals Private Limited
FY 2025 filings availableAikvira Pharmaceuticals Private Limited reported revenue of ₹1 Lakh (up 230% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 230% in the latest year. EBITDA rose 77% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹49,222 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹36,425 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 49.1% | |
| Net Profit Margin | 36.4% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Aikvira Pharmaceuticals Private Limited, buy the company report.
Board of directors of Aikvira Pharmaceuticals Private Limited
Aikvira Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sidharth Sitaram Lad | Director | 28 Mar 2025 | 1 Years 7 Months | Current |
| Richa Sharma | Director | 28 Mar 2025 | 1 Years 7 Months | Current |
Peer comparison
Aikvira Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mapaex Global Private Limited | ₹1.03 Lakh (FY 2024) | -11.0% | Bhopal, Madhya Pradesh, India | |||
| Organspharma Labs Private Limited | ₹1.02 Lakh (FY 2022) | Agra, Uttar Pradesh, India | ||||
| Bloom Biocare Pharma Private Limited | ₹1.01 Lakh (FY 2024) | Chennai, Tamil Nadu, India | ||||
| Green Quick Pharmaceuticals Private Limited | ₹1.01 Lakh (FY 2024) | 276.0% | Delhi, India | |||
| Fourtiza Healthcare Private Limited | ₹1.01 Lakh (FY 2023) | Miraj, Maharashtra, India | ||||
| Aikvira Pharmaceuticals Private Limitedthis company | ₹1 Lakh (FY 2025) | ₹36,425 | 36.4% | 230.0% | Thane, Maharashtra, India | |
| Nazwin Pharmaceuticals Private Limited | ₹1 Lakh (FY 2019) | Nagpur, Maharashtra, India | ||||
| Makson Formulations Pvt Ltd | ₹1 Lakh (FY 2025) | 0.0% | Surendranagar, Gujarat, India | |||
| Retino Pharmaceuticals Private Limited | ₹1 Lakh (FY 2025) | -69.0% | Allahabad, Uttar Pradesh, India | |||
| Kasturba Pharmaceuticals Private Limited | ₹1 Lakh (FY 2024) | Bangalore, Karnataka, India | ||||
| Colikine Pharmaceuticals Private Limited | ₹1 Lakh (FY 2018) | -61.0% | Ghazipur, Uttar Pradesh, India |
To see the full peer comparison of Aikvira Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Aikvira Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aikvira Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aikvira Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aikvira Pharmaceuticals Private Limited has 4 board changes on record since 2025: 2 appointments and 2 cessations. The latest: Richa Sharma was appointed as Director on 28 Mar 2025.
Frequently asked questions
Aikvira Pharmaceuticals is an active private limited company based in Thane, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 12 May 2023 (3+ years old) and is registered under CIN U21009MH2023PTC402838.
Aikvira Pharmaceuticals has 2 current directors:
- Sidharth Sitaram Lad - Director
- Richa Sharma - Director
The latest financial statements of Aikvira Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The CIN (Corporate Identification Number) of Aikvira Pharmaceuticals is U21009MH2023PTC402838. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aikvira Pharmaceuticals was incorporated on 12 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Aikvira Pharmaceuticals by revenue are Mapaex Global Private Limited, Organspharma Labs Private Limited, Bloom Biocare Pharma Private Limited, Green Quick Pharmaceuticals Private Limited, Fourtiza Healthcare Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Richa Sharma was appointed as Director on 28 Mar 2025. Sanket Suresh Patil ceased to be Director on 28 Mar 2025. Sidharth Sitaram Lad was appointed as Director on 28 Mar 2025. Aikvira Pharmaceuticals has 4 board changes on record in total.
The registered office of Aikvira Pharmaceuticals is at Office No 16 1st Flr Gb, Road Tropical Lagoon Tl5, Thane, Maharashtra, India – 400615.
Aikvira Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Aikvira Pharmaceuticals can be reached at its registered office: Office No 16 1st Flr Gb, Road Tropical Lagoon Tl5, Thane, Maharashtra, India – 400615.
Aikvira Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
